Trade GlaxoSmithKline plc (Extended hours) - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.27 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 36.79 |
| Open | 36.8 |
| 1-Year Change | -12.3% |
| Day's Range | 35.96 - 36.8 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 36.48 | 0.03 | 0.08% | 36.45 | 36.62 | 35.75 |
| Feb 20, 2025 | 36.80 | 0.55 | 1.52% | 36.25 | 37.16 | 36.16 |
| Feb 19, 2025 | 36.28 | -0.23 | -0.63% | 36.51 | 36.63 | 36.06 |
| Feb 18, 2025 | 36.45 | 0.46 | 1.28% | 35.99 | 36.79 | 35.99 |
| Feb 14, 2025 | 36.04 | -0.21 | -0.58% | 36.25 | 36.55 | 35.97 |
| Feb 13, 2025 | 36.51 | 0.39 | 1.08% | 36.12 | 36.56 | 35.95 |
| Feb 12, 2025 | 36.04 | 0.11 | 0.31% | 35.93 | 36.20 | 35.47 |
| Feb 11, 2025 | 36.15 | -0.16 | -0.44% | 36.31 | 36.37 | 35.65 |
| Feb 10, 2025 | 36.28 | 0.32 | 0.89% | 35.96 | 36.85 | 35.96 |
| Feb 7, 2025 | 35.85 | -0.56 | -1.54% | 36.41 | 36.61 | 35.83 |
| Feb 6, 2025 | 36.30 | -1.10 | -2.94% | 37.40 | 37.56 | 35.93 |
| Feb 5, 2025 | 37.49 | 0.79 | 2.15% | 36.70 | 37.85 | 36.52 |
| Feb 4, 2025 | 34.42 | -0.44 | -1.26% | 34.86 | 35.04 | 34.17 |
| Feb 3, 2025 | 34.81 | 0.13 | 0.37% | 34.68 | 35.09 | 34.45 |
| Jan 31, 2025 | 35.05 | -0.18 | -0.51% | 35.23 | 35.46 | 34.94 |
| Jan 30, 2025 | 35.17 | 0.36 | 1.03% | 34.81 | 35.53 | 34.69 |
| Jan 29, 2025 | 34.93 | 0.09 | 0.26% | 34.84 | 35.19 | 34.57 |
| Jan 28, 2025 | 34.78 | -0.19 | -0.54% | 34.97 | 35.53 | 34.68 |
| Jan 27, 2025 | 34.95 | 0.30 | 0.87% | 34.65 | 35.45 | 34.54 |
| Jan 24, 2025 | 34.09 | 0.05 | 0.15% | 34.04 | 34.25 | 33.70 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com